{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:21:11Z","timestamp":1791566471436,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","award":["OE 0460 ED003"],"award-info":[{"award-number":["OE 0460 ED003"]}],"id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03VP01062"],"award-info":[{"award-number":["03VP01062"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral squamous cell carcinoma (OSCC), an HPV-negative head and neck cancer, frequently metastasizes to the regional lymph nodes but only occasionally beyond. Initial phases of metastasis are associated with an epithelial\u2013mesenchymal transition (EMT), while the consolidation phase is associated with mesenchymal\u2013epithelial transition (MET). This dynamic is referred to as epithelial\u2013mesenchymal plasticity (EMP). While it is known that EMP is essential for cancer cell invasion and metastatic spread, less is known about the heterogeneity of EMP states and even less about the heterogeneity between primary and metastatic lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To assess both the heterogeneity of EMP states in OSCC cells and their effects on stromal cells, we performed single-cell RNA sequencing (scRNAseq) of 5 primary tumors, 9 matching metastatic and 5 tumor-free lymph nodes and re-analyzed publicly available scRNAseq data of 9 additional primary tumors. For examining the cell type composition, we performed bulk transcriptome sequencing. Protein expression of selected genes were confirmed by immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From the 23 OSCC lesions, the single cell transcriptomes of a total of 7263 carcinoma cells were available for in-depth analyses. We initially focused on one lesion to avoid confounding inter-patient heterogeneity and identified OSCC cells expressing genes characteristic of different epithelial and partial EMT stages. RNA velocity and the increase in inferred copy number variations indicated a progressive trajectory towards epithelial differentiation in this metastatic lesion, i.e., cells likely underwent MET. Extension to all samples revealed a less stringent but essentially similar pattern. Interestingly, MET cells show increased activity of the EMT-activator ZEB1. Immunohistochemistry confirmed that ZEB1 was co-expressed with the epithelial marker cornifin B in individual tumor cells. The lack of E-cadherin mRNA expression suggests this is a partial MET. Within the tumor microenvironment we found immunomodulating fibroblasts that were maintained in primary and metastatic OSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals that EMP enables different partial EMT and epithelial phenotypes of OSCC cells, which are endowed with capabilities essential for the different stages of the metastatic process, including maintenance of cellular integrity. During MET, ZEB1 appears to be functionally active, indicating a more complex role of ZEB1 than mere induction of EMT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04102-w","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:02:35Z","timestamp":1681884155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Mesenchymal\u2013epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression"],"prefix":"10.1186","volume":"21","author":[{"given":"Kai","family":"Horny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sproll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Peiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Furtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gravemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas H.","family":"Stoecklein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivelina","family":"Spassova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-653X","authenticated-orcid":false,"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"issue":"1","key":"4102_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"4102_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","volume":"16","author":"JD Cramer","year":"2019","unstructured":"Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16(11):669\u201383.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4102_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang Ruby Y-J, Jackson Rebecca A, Thiery JP. EMT: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"issue":"6","key":"4102_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell. 2020;21(6):341\u201352.","journal-title":"Nat Rev Mol Cell"},{"issue":"18","key":"4102_CR5","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40(18): e108647.","journal-title":"EMBO J"},{"issue":"11","key":"4102_CR6","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.celrep.2015.11.025","volume":"13","author":"MY del Pozo","year":"2015","unstructured":"del Pozo MY, Park D, Ramachandran A, Ombrato L, Calvo F, Chakravarty P, et al. Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization. Cell Rep. 2015;13(11):2456\u201369.","journal-title":"Cell Rep"},{"issue":"9","key":"4102_CR7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41588-019-0489-5","volume":"51","author":"JL McFaline-Figueroa","year":"2019","unstructured":"McFaline-Figueroa JL, Hill AJ, Qiu X, Jackson D, Shendure J, Trapnell C. A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition. Nat Genet. 2019;51(9):1389\u201398.","journal-title":"Nat Genet"},{"issue":"1","key":"4102_CR8","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/s41467-020-16066-2","volume":"11","author":"DP Cook","year":"2020","unstructured":"Cook DP, Vanderhyden BC. Context specificity of the EMT transcriptional response. Nat Commun. 2020;11(1):2142.","journal-title":"Nat Commun"},{"issue":"1","key":"4102_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","volume":"124","author":"SV Vasaikar","year":"2021","unstructured":"Vasaikar SV, Deshmukh AP, den Hollander P, Addanki S, Kuburich NA, Kudaravalli S, et al. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br J Cancer. 2021;124(1):259\u201369.","journal-title":"Br J Cancer"},{"issue":"7","key":"4102_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171(7):1611-24.e24.","journal-title":"Cell"},{"issue":"7702","key":"4102_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556(7702):463\u20138.","journal-title":"Nature"},{"issue":"32","key":"4102_CR12","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1038\/s41388-021-01868-5","volume":"40","author":"A Pal","year":"2021","unstructured":"Pal A, Barrett TF, Paolini R, Parikh A, Puram SV. Partial EMT in head and neck cancer biology: a spectrum instead of a switch. Oncogene. 2021;40(32):5049\u201365.","journal-title":"Oncogene"},{"issue":"19","key":"4102_CR13","doi-asserted-by":"publisher","first-page":"27067","DOI":"10.18632\/oncotarget.8166","volume":"7","author":"MK Jolly","year":"2016","unstructured":"Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, et al. Stability of the hybrid epithelial\/mesenchymal phenotype. Oncotarget. 2016;7(19):27067\u201384.","journal-title":"Oncotarget"},{"issue":"11","key":"4102_CR14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker GS, Greenwald AC, Tal R, Orlova Z, Cuoco MS, McFarland JM, et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat Genet. 2020;52(11):1208\u201318.","journal-title":"Nat Genet"},{"issue":"1","key":"4102_CR15","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1038\/s41467-019-13441-6","volume":"10","author":"LG Karacosta","year":"2019","unstructured":"Karacosta LG, Anchang B, Ignatiadis N, Kimmey SC, Benson JA, Shrager JB, et al. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nat Commun. 2019;10(1):5587.","journal-title":"Nat Commun"},{"issue":"2","key":"4102_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","volume":"182","author":"AL Ji","year":"2020","unstructured":"Ji AL, Rubin AJ, Thrane K, Jiang S, Reynolds DL, Meyers RM, et al. multimodal analysis of composition and spatial architecture in human squamous cell carcinoma. Cell. 2020;182(2):497-514.e22.","journal-title":"Cell"},{"issue":"1","key":"4102_CR17","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.1038\/s41467-021-27619-4","volume":"12","author":"CHL K\u00fcrten","year":"2021","unstructured":"K\u00fcrten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021;12(1):7338.","journal-title":"Nat Commun"},{"issue":"9","key":"4102_CR18","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-19-2244","volume":"26","author":"I Spassova","year":"2020","unstructured":"Spassova I, Ugurel S, Terheyden P, Sucker A, Hassel JC, Ritter C, et al. Predominance of central memory T cells with high T-cell receptor repertoire diversity is associated with response to PD-1\/PD-L1 inhibition in merkel cell carcinoma. Clin Cancer Res. 2020;26(9):2257\u201367.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4102_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u201382.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"4102_CR20","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188746","volume":"15","author":"MD Luecken","year":"2019","unstructured":"Luecken MD, Theis FJ. Current best practices in single-cell RNA-seq analysis: a tutorial. Mol Syst Biol. 2019;15(6): e8746.","journal-title":"Mol Syst Biol"},{"issue":"13","key":"4102_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573-87.e29.","journal-title":"Cell"},{"issue":"1","key":"4102_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20(1):296.","journal-title":"Genome Biol"},{"issue":"6282","key":"4102_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189.","journal-title":"Science"},{"issue":"2","key":"4102_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"6","key":"4102_CR25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco G, Lee B, Xu W, Mustafah S, Hwang YY, Carr\u00e9 C, et al. RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 2019;26(6):1627-40.e7.","journal-title":"Cell Rep"},{"key":"4102_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/060012","author":"G Korotkevich","year":"2021","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/060012.","journal-title":"bioRxiv"},{"issue":"6","key":"4102_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"43","key":"4102_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4102_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 2013;14(1):7.","journal-title":"BMC Bioinform"},{"issue":"1","key":"4102_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom. 2018;19(1):477.","journal-title":"BMC Genom"},{"issue":"7719","key":"4102_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno G, Soldatov R, Zeisel A, Braun E, Hochgerner H, Petukhov V, et al. RNA velocity of single cells. Nature. 2018;560(7719):494\u20138.","journal-title":"Nature"},{"issue":"8","key":"4102_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 2019;29(8):1363\u201375.","journal-title":"Genome Res"},{"issue":"1","key":"4102_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13059-020-1949-z","volume":"21","author":"CH Holland","year":"2020","unstructured":"Holland CH, Tanevski J, Perales-Pat\u00f3n J, Gleixner J, Kumar MP, Mereu E, et al. Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data. Genome Biol. 2020;21(1):36.","journal-title":"Genome Biol"},{"issue":"8","key":"4102_CR34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.3593","volume":"48","author":"MJ Alvarez","year":"2016","unstructured":"Alvarez MJ, Shen Y, Giorgi FM, Lachmann A, Ding BB, Ye BH, et al. Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat Genet. 2016;48(8):838\u201347.","journal-title":"Nat Genet"},{"key":"4102_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016."},{"issue":"18","key":"4102_CR36","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139.","journal-title":"Bioinformatics"},{"key":"4102_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144552","volume":"741","author":"D-D Guo","year":"2020","unstructured":"Guo D-D, Xie K-F, Luo X-J. Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC. Gene. 2020;741: 144552.","journal-title":"Gene"},{"issue":"6","key":"4102_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.molcel.2017.06.002","volume":"66","author":"M Ivan","year":"2017","unstructured":"Ivan M, Kaelin WG. The EGLN-HIF O2-sensing system: multiple inputs and feedbacks. Mol Cell. 2017;66(6):772\u20139.","journal-title":"Mol Cell"},{"issue":"20","key":"4102_CR39","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(20):3589\u201394.","journal-title":"J Cell Sci"},{"issue":"3","key":"4102_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cmet.2011.08.004","volume":"14","author":"RJ DeBerardinis","year":"2011","unstructured":"DeBerardinis RJ. Serine metabolism: some tumors take the road less traveled. Cell Metab. 2011;14(3):285\u20136.","journal-title":"Cell Metab"},{"issue":"34","key":"4102_CR41","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1038\/onc.2014.388","volume":"34","author":"E Mart\u00edn-Villar","year":"2015","unstructured":"Mart\u00edn-Villar E, Borda-d\u2019Agua B, Carrasco-Ramirez P, Renart J, Parsons M, Quintanilla M, et al. Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability. Oncogene. 2015;34(34):4531\u201344.","journal-title":"Oncogene"},{"issue":"6","key":"4102_CR42","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/ijc.10903","volume":"103","author":"AG de Nooij-van Dalen","year":"2003","unstructured":"de Nooij-van Dalen AG, van Dongen GAMS, Smeets SJ, Nieuwenhuis EJC, Stigter-van Walsum M, Snow GB, et al. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer. 2003;103(6):768\u201374.","journal-title":"Int J Cancer"},{"issue":"4","key":"4102_CR43","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1073\/pnas.95.4.1735","volume":"95","author":"RE Reiter","year":"1998","unstructured":"Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA. 1998;95(4):1735\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4102_CR44","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1038\/s41598-021-89789-x","volume":"11","author":"K Zhou","year":"2021","unstructured":"Zhou K, Arslanturk S, Craig DB, Heath E, Draghici S. Discovery of primary prostate cancer biomarkers using cross cancer learning. Sci Rep. 2021;11(1):10433.","journal-title":"Sci Rep"},{"issue":"12","key":"4102_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"5","key":"4102_CR46","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.jid.2016.03.046","volume":"137","author":"IY Oh","year":"2017","unstructured":"Oh IY, de Guzman SC. The molecular revolution in cutaneous biology: EDC and locus control. J Invest Dermatol. 2017;137(5):e101\u20134.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"4102_CR47","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nmeth.2967","volume":"11","author":"PV Kharchenko","year":"2014","unstructured":"Kharchenko PV, Silberstein L, Scadden DT. Bayesian approach to single-cell differential expression analysis. Nat Methods. 2014;11(7):740\u20132.","journal-title":"Nat Methods"},{"issue":"1","key":"4102_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","volume":"21","author":"MP Stemmler","year":"2019","unstructured":"Stemmler MP, Eccles RL, Brabletz S, Brabletz T. Non-redundant functions of EMT transcription factors. Nat Cell Biol. 2019;21(1):102\u201312.","journal-title":"Nat Cell Biol"},{"issue":"24","key":"4102_CR49","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1038\/onc.2010.102","volume":"29","author":"E S\u00e1nchez-Till\u00f3","year":"2010","unstructured":"S\u00e1nchez-Till\u00f3 E, L\u00e1zaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI\/SNF chromatin-remodeling protein BRG1. Oncogene. 2010;29(24):3490\u2013500.","journal-title":"Oncogene"},{"issue":"11","key":"4102_CR50","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ni1513","volume":"8","author":"A Link","year":"2007","unstructured":"Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol. 2007;8(11):1255\u201365.","journal-title":"Nat Immunol"},{"issue":"5","key":"4102_CR51","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.immuni.2018.04.006","volume":"48","author":"LB Rodda","year":"2018","unstructured":"Rodda LB, Lu E, Bennett ML, Sokol CL, Wang X, Luther SA, et al. Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneity. Immunity. 2018;48(5):1014-28.e6.","journal-title":"Immunity"},{"issue":"4","key":"4102_CR52","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4049\/jimmunol.1402520","volume":"194","author":"FD Brown","year":"2015","unstructured":"Brown FD, Turley SJ. Fibroblastic reticular cells: organization and regulation of the T lymphocyte life cycle. J Immunol. 2015;194(4):1389.","journal-title":"J Immunol"},{"issue":"1","key":"4102_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13277-012-0511-3","volume":"34","author":"HH Oliveira-Neto","year":"2013","unstructured":"Oliveira-Neto HH, de Souza PPC, da Silva MRB, Mendon\u00e7a EF, Silva TA, Batista AC. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Tumor Biol. 2013;34(1):65\u201370.","journal-title":"Tumor Biol"},{"issue":"31","key":"4102_CR54","doi-asserted-by":"publisher","first-page":"eabh2169","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson M, Zhang C, M\u00e9ar L, Zhong W, Digre A, Katona B, et al. A single-cell type transcriptomics map of human tissues. Sci Adv. 2021;7(31):eabh2169.","journal-title":"Sci Adv"},{"issue":"1","key":"4102_CR55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-020-0922-4","volume":"3","author":"L Sol\u00e9-Boldo","year":"2020","unstructured":"Sol\u00e9-Boldo L, Raddatz G, Sch\u00fctz S, Mallm J-P, Rippe K, Lonsdorf AS, et al. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol. 2020;3(1):188.","journal-title":"Commun Biol"},{"issue":"12","key":"4102_CR56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","volume":"19","author":"ED Williams","year":"2019","unstructured":"Williams ED, Gao D, Redfern A, Thompson EW. Controversies around epithelial\u2013mesenchymal plasticity in cancer metastasis. Nat Rev Cancer. 2019;19(12):716\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4102_CR57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.devcel.2019.04.026","volume":"49","author":"R Derynck","year":"2019","unstructured":"Derynck R, Weinberg RA. EMT and cancer: more than meets the eye. Dev Cell. 2019;49(3):313\u20136.","journal-title":"Dev Cell"},{"issue":"2","key":"4102_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4102_CR59","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2012.09.022","volume":"22","author":"JH Tsai","year":"2012","unstructured":"Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012;22(6):725\u201336.","journal-title":"Cancer Cell"},{"issue":"1","key":"4102_CR60","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1038\/s41467-019-11738-0","volume":"10","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Dai Z, Locasale JW. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat Commun. 2019;10(1):3763.","journal-title":"Nat Commun"},{"issue":"6","key":"4102_CR61","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, et al. EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell. 2018;45(6):681-95.e4.","journal-title":"Dev Cell"},{"issue":"5","key":"4102_CR62","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19(5):518\u201329.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4102_CR63","doi-asserted-by":"publisher","first-page":"108990","DOI":"10.1016\/j.celrep.2021.108990","volume":"35","author":"JL Carstens","year":"2021","unstructured":"Carstens JL, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews KM, et al. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep. 2021;35(2):108990.","journal-title":"Cell Rep"},{"issue":"6","key":"4102_CR64","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/embor.2008.74","volume":"9","author":"U Burk","year":"2008","unstructured":"Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9(6):582\u20139.","journal-title":"EMBO Rep"},{"issue":"5","key":"4102_CR65","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1167\/iovs.09-4677","volume":"51","author":"S Li","year":"2010","unstructured":"Li S, Gallup M, Chen YT, McNamara NA. Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2010;51(5):2466\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"4102_CR66","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3013","volume":"16","author":"P Zhang","year":"2014","unstructured":"Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16(9):864\u201375.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"4102_CR67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.cdd.4400988","volume":"9","author":"RG Oshima","year":"2002","unstructured":"Oshima RG. Apoptosis and keratin intermediate filaments. Cell Death Differ. 2002;9(5):486\u201392.","journal-title":"Cell Death Differ"},{"issue":"9","key":"4102_CR68","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","volume":"27","author":"PM Galbo Jr","year":"2021","unstructured":"Galbo PM Jr, Zang X, Zheng D. Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance. Clin Cancer Res. 2021;27(9):2636\u201347.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4102_CR69","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1084\/jem.194.6.855","volume":"194","author":"I Kurth","year":"2001","unstructured":"Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med. 2001;194(6):855\u201361.","journal-title":"J Exp Med"},{"issue":"22","key":"4102_CR70","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.1158\/0008-5472.CAN-04-2056","volume":"64","author":"TD Shellenberger","year":"2004","unstructured":"Shellenberger TD, Wang M, Gujrati M, Jayakumar A, Strieter RM, Burdick MD, et al. BRAK\/CXCL14 Is a Potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Can Res. 2004;64(22):8262\u201370.","journal-title":"Can Res"},{"key":"4102_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107681","volume":"97","author":"A Gowhari Shabgah","year":"2021","unstructured":"Gowhari Shabgah A, Haleem Al-qaim Z, Markov A, Valerievich Yumashev A, Ezzatifar F, Ahmadi M, et al. Chemokine CXCL14; a double-edged sword in cancer development. Int Immunopharmacol. 2021;97: 107681.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"4102_CR72","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1111\/j.1349-7006.2009.01281.x","volume":"100","author":"S Ozawa","year":"2009","unstructured":"Ozawa S, Kato Y, Ito S, Komori R, Shiiki N, Tsukinoki K, et al. Restoration of BRAK \/ CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma. Cancer Sci. 2009;100(11):2202\u20139.","journal-title":"Cancer Sci"},{"issue":"11","key":"4102_CR73","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1158\/0008-5472.CAN-13-2740","volume":"74","author":"M Augsten","year":"2014","unstructured":"Augsten M, Sj\u00f6berg E, Frings O, Vorrink SU, Frijhoff J, Olsson E, et al. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. Cancer Res. 2014;74(11):2999\u20133010.","journal-title":"Cancer Res"},{"issue":"3","key":"4102_CR74","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","volume":"49","author":"F Kai","year":"2019","unstructured":"Kai F, Drain AP, Weaver VM. The extracellular matrix modulates the metastatic journey. Dev Cell. 2019;49(3):332\u201346.","journal-title":"Dev Cell"},{"issue":"1","key":"4102_CR75","doi-asserted-by":"publisher","first-page":"20404","DOI":"10.1038\/s41598-022-24533-7","volume":"12","author":"J Yin","year":"2022","unstructured":"Yin J, Zheng S, He X, Huang Y, Hu L, Qin F, et al. Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories. Sci Rep. 2022;12(1):20404.","journal-title":"Sci Rep"},{"issue":"9","key":"4102_CR76","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/carcin\/bgac070","volume":"43","author":"D Wang","year":"2022","unstructured":"Wang D, Pei P, Shea FF, Bissonnette C, Nieto K, Din C, et al. Fenretinide combines perturbation of signaling kinases, cell\u2013extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells. Carcinogenesis. 2022;43(9):851\u201364.","journal-title":"Carcinogenesis"},{"issue":"16","key":"4102_CR77","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","volume":"23","author":"L Shaashua","year":"2017","unstructured":"Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, Shabtai M, et al. Perioperative COX-2 and \u03b2-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin Cancer Res. 2017;23(16):4651\u201361.","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1186\/s12967-024-04998-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04102-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04102-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04102-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:05:27Z","timestamp":1710403527000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04102-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4102"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04102-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.03.478962","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12967-024-04998-y","URL":"https:\/\/doi.org\/10.1186\/s12967-024-04998-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from each patient and the Ethics Committee of the Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf (#3090) approved the study. All procedures involving human participants are in accordance with the ethical standards of the institutional and research committee and with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JCB is receiving speaker\u2019s bureau honoraria from Amgen, Pfizer, MerckSerono, Recordati and Sanofi, is a paid consultant\/advisory board member\/DSMB member for Boehringer Ingelheim, InProTher, MerckSerono, Pfizer, 4SC, and Sanofi\/Regeneron. His group receives research grants from Bristol-Myers Squibb, Merck Serono, HTG, IQVIA, and Alcedis. None of these activities are related to the present manuscript. The other authors including KH, CS, LP, FF, PG, JG, NS, IS declare no competing of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}